MICROENCAPSULATION USING POLY(L-LACTIC ACID) .4. RELEASE PROPERTIES OF MICROCAPSULES CONTAINING PHENOBARBITONE

被引:41
作者
JALIL, R [1 ]
NIXON, JR [1 ]
机构
[1] UNIV LONDON,KINGS COLL,CHELSEA DEPT PHARM,MANRESA RD,LONDON SW3 6LX,ENGLAND
关键词
D O I
10.3109/02652049009028423
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Microcapsules containing phenobarbitone were prepared from polyL-lactic acid using a water/oil emulsification and evaporation process. Polymers of three different molecular weights were used. Particle size was found to increase with an increase in core loading and polymer molecular weight. Release studies were carried out at buffer pHs of 2 and 9 at 37°C. The release mechanism was found to follow a square root of time relationship. Almost 90 per cent of the phenobarbitone was released within 2 h. The release rate was not a direct relationship with the phenobarbitone content of the microcapsules because of the differing size and surface area of the microcapsules. However, normalized release rates release rate/specific surface area were found to increase linearly with the increase in phenobarbitone content. First order release plots of the data were not found consistent with the core loading. The release at a buffer pH of 9 was very rapid and with some microcapsules was faster than solution of the uncoated crystalline phenobarbitone. At pH 2 release was also very rapid, due to the presence of large pores in the microcapsules of high molecular weight polymers. Release from the microcapsules prepared from low molecular weight polymer was slower than those from high molecular weight polymers. Microcapsules from the low molecular weight polymer were found to swell in the dissolution medium and finally disintegrated into smaller fragments. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:53 / 66
页数:14
相关论文
共 19 条
[1]  
Benoit J.P., Benita S., Puisieux F., Thies C., Davis S.S., Ilium L., McVie J.G., Tomlinson E., Stability and release kinetics of drug incorporated within microspheres, Microsphere and Drug Therapy, Pharmaceutical, Immunological and Medical Aspects, pp. 95-102, (1984)
[2]  
Deasy P.B., Microencapsulation and Related Drug Process, (1984)
[3]  
Fessi H., Marty J.P., Puisieux F., Cartensen J.T., Square root of time dependence of matrix formulations with low drug content, Journal of Pharmaceutical Science, 71, pp. 749-752, (1982)
[4]  
Hutchinson F.G., Furr B.J.A., Biodegradable carriers for the sustained release of polypeptides, Trends in Biological Technology, 5, pp. 102-106, (1987)
[5]  
Jalil R., Nixon J.R., Microencapsulation using poly(L-lactic acid), I: Microcapsule properties affected by the preparative technique, Journal of Microencapsulation, 6, pp. 473-484, (1989)
[6]  
Jalil R., Nixon J.R., Microencapsulation using poly(L-lactic acid), III: Effect of polymer molecular weight on the microcapsule properties, Journal of Microencapsulation, 7, pp. 41-52, (1990)
[7]  
Kulkarni R.K., Pani K.C., Neuman C., Leonard F., Polylactic acid for surgical implants, Archives of Surgery, 93, pp. 839-843, (1966)
[8]  
Kulkarni R.K., Moore E.G., Hegyeli A.F., Leonard F., Biodegradable poly(lactic acid) polymers, J. Biomedical Material Research, 5, pp. 169-181, (1971)
[9]  
Leelarasamee N., Howard S.A., Malanga C.J., Luzzi L.A., Hogan T.F., Kandzari S.J., Ma J.K.H., Kinetics of drug release from polylactic acid-hydrocortisone microcapsules, Journal of Microencapsulation, 3, pp. 171-179, (1986)
[10]  
Luzzi L.A., Palmieri A., Lim F., An overview of pharmaceutical applications, Biomedical Application of Microencapsulation, pp. 1-17, (1984)